Abiopharma

🔍 Hochman David P (Director)

Company: Orchestra BioMed Holdings, Inc. (OBIO)

Report Date: 2025-08-21

Detailed Transactions and Holdings:

• Acquired 6,000 shares of Common Stock, par value $0.0001 per share ("Common Stock") at $2.49 per share (Direct)
  Date: 2025-08-21 | Code: P | equity_swap_involved: 0 | shares_owned_after: 651,460.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: H | nature_of_ownership: By the DPH 2008 Trust | shares_owned_after: 449,331.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: H | nature_of_ownership: By the Solomon Ascher Hochman 2019 Trust | shares_owned_after: 2,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: H | nature_of_ownership: By the Hannah Hochman 2019 Trust | shares_owned_after: 2,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: H | nature_of_ownership: By the Judah Herman Hochman 2019 Trust | shares_owned_after: 2,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-21 | Code: H | nature_of_ownership: By the NSH 2008 Family Trust | shares_owned_after: 3,140.00

Footnotes:

• F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.49 to $2.50. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• REMARKS: Chief Executive Officer and Chairperson